Contacts   Site Map
Search
Home    Pipeline    Nektar Partnered Products    Approved or Filed Products    

Mircera™
(continuous erythropoietin receptor activator)

Partner: Roche
Indication: Anemia associated with chronic kidney disease
Status: Filed in the U.S. and EU

Nektar has a collaboration with Roche to provide Advanced PEGylation Technology for Mircera™ (continuous erythropoietin receptor activator). Mircera™ is being developed to treat anemia associated with chronic renal disease by stimulating red blood cell production.

Privacy | Terms of Use | Compliance Policy | Trademarks